Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
Clicks: 174
ID: 115524
2019
AbstractBackground. Sustaining clinical remission is an important treatment goal in moderate-to-severe UC. This post hoc exploratory analysis assessed the long
| Reference Key |
g2019inflammatorysustained
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Feagan, Brian G;Schreiber, Stefan;Wolf, Douglas C;Axler, Jeffrey L;Kaviya, Arpeat;James, Alexandra;Curtis, Rebecca I;Geransar, Parnia;Stallmach, Andreas;Ehehalt, Robert;Bokemeyer, Bernd;Khalid, Javaria Mona;O’Byrne, Sharon; |
| Journal | inflammatory bowel diseases |
| Year | 2019 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.